Market Place
Sourcing Support
Zydus and ICMR Start Phase 2 Trial of Desidustat for Sickle Cell
15 Oct 2024 //
INDPHARMAPOST
Zydus gets DCGI nod for drug to treat anaemia linked with kidney disease
07 Mar 2022 //
BUSINESS-STANDARD
SEC recommends permission to Zydus Cadila’s Desidustat subject to conditions
20 Jan 2022 //
PHARMABIZ
Zydus` Desidustat shows efficacy and safety in treating Hypoxia in COVID-19
25 Jan 2021 //
BIOSPACE
Zydus receives USFDA approval to initiate trials of Desidustat in Chemotherapy
23 Jul 2020 //
BUSINESS-STANDARD
Zydus Cadila receives Mexican regulatory approval to test COVID-19, desidustat
06 Jul 2020 //
PHARMABIZ
Zydus inks pact with China Medical System to market Desidustat in Greater China
21 Jan 2020 //
BUSINESS LINE
Zydus Cadila announces phase III trial of Desidustat
17 Apr 2019 //
BIOSPECTRUMASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.